714 related articles for article (PubMed ID: 33059707)
1. Accuracy and reproducibility of somatic point mutation calling in clinical-type targeted sequencing data.
Karimnezhad A; Palidwor GA; Thavorn K; Stewart DJ; Campbell PA; Lo B; Perkins TJ
BMC Med Genomics; 2020 Oct; 13(1):156. PubMed ID: 33059707
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of somatic variant calling on matched FF and FFPE WGS samples.
de Schaetzen van Brienen L; Larmuseau M; Van der Eecken K; De Ryck F; Robbe P; Schuh A; Fostier J; Ost P; Marchal K
BMC Med Genomics; 2020 Jul; 13(1):94. PubMed ID: 32631411
[TBL] [Abstract][Full Text] [Related]
3. Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material.
de Leng WW; Gadellaa-van Hooijdonk CG; Barendregt-Smouter FA; Koudijs MJ; Nijman I; Hinrichs JW; Cuppen E; van Lieshout S; Loberg RD; de Jonge M; Voest EE; de Weger RA; Steeghs N; Langenberg MH; Sleijfer S; Willems SM; Lolkema MP
PLoS One; 2016; 11(2):e0149405. PubMed ID: 26919633
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics and DNA-extraction strategies to reliably detect genetic variants from FFPE breast tissue samples.
Bhagwate AV; Liu Y; Winham SJ; McDonough SJ; Stallings-Mann ML; Heinzen EP; Davila JI; Vierkant RA; Hoskin TL; Frost M; Carter JM; Radisky DC; Cunningham JM; Degnim AC; Wang C
BMC Genomics; 2019 Sep; 20(1):689. PubMed ID: 31477010
[TBL] [Abstract][Full Text] [Related]
5. Amplicon-Based Targeted Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Tissue.
Strengman E; Barendrecht-Smouter FAS; de Voijs C; de Vree P; Nijman IJ; de Leng WWJ
Methods Mol Biol; 2019; 1908():1-17. PubMed ID: 30649717
[TBL] [Abstract][Full Text] [Related]
6. Quality control material for the detection of somatic mutations in fixed clinical specimens by next-generation sequencing.
Dumur CI; Almenara JA; Powers CN; Ferreira-Gonzalez A
Diagn Pathol; 2015 Sep; 10():169. PubMed ID: 26376646
[TBL] [Abstract][Full Text] [Related]
7. Comparison of somatic variant detection algorithms using Ion Torrent targeted deep sequencing data.
Wang Q; Kotoula V; Hsu PC; Papadopoulou K; Ho JWK; Fountzilas G; Giannoulatou E
BMC Med Genomics; 2019 Dec; 12(Suppl 9):181. PubMed ID: 31874647
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive benchmarking of SNV callers for highly admixed tumor data.
Bohnert R; Vivas S; Jansen G
PLoS One; 2017; 12(10):e0186175. PubMed ID: 29020110
[TBL] [Abstract][Full Text] [Related]
9. SiNVICT: ultra-sensitive detection of single nucleotide variants and indels in circulating tumour DNA.
Kockan C; Hach F; Sarrafi I; Bell RH; McConeghy B; Beja K; Haegert A; Wyatt AW; Volik SV; Chi KN; Collins CC; Sahinalp SC
Bioinformatics; 2017 Jan; 33(1):26-34. PubMed ID: 27531099
[TBL] [Abstract][Full Text] [Related]
10. Somatic Mutation Screening Using Archival Formalin-Fixed, Paraffin-Embedded Tissues by Fluidigm Multiplex PCR and Illumina Sequencing.
Wang M; Escudero-Ibarz L; Moody S; Zeng N; Clipson A; Huang Y; Xue X; Grigoropoulos NF; Barrans S; Worrillow L; Forshew T; Su J; Firth A; Martin H; Jack A; Brugger K; Du MQ
J Mol Diagn; 2015 Sep; 17(5):521-32. PubMed ID: 26165823
[TBL] [Abstract][Full Text] [Related]
11. TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy.
Gray PN; Vuong H; Tsai P; Lu HM; Mu W; Hsuan V; Hoo J; Shah S; Uyeda L; Fox S; Patel H; Janicek M; Brown S; Dobrea L; Wagman L; Plimack E; Mehra R; Golemis EA; Bilusic M; Zibelman M; Elliott A
Oncotarget; 2016 Oct; 7(42):68206-68228. PubMed ID: 27626691
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Nine Somatic Variant Callers for Detection of Somatic Mutations in Exome and Targeted Deep Sequencing Data.
Krøigård AB; Thomassen M; Lænkholm AV; Kruse TA; Larsen MJ
PLoS One; 2016; 11(3):e0151664. PubMed ID: 27002637
[TBL] [Abstract][Full Text] [Related]
13. Mutational profiling of micro-dissected pre-malignant lesions from archived specimens.
Nachmanson D; Steward J; Yao H; Officer A; Jeong E; O'Keefe TJ; Hasteh F; Jepsen K; Hirst GL; Esserman LJ; Borowsky AD; Harismendy O
BMC Med Genomics; 2020 Nov; 13(1):173. PubMed ID: 33208147
[TBL] [Abstract][Full Text] [Related]
14. Comparing the performance of selected variant callers using synthetic data and genome segmentation.
Bian X; Zhu B; Wang M; Hu Y; Chen Q; Nguyen C; Hicks B; Meerzaman D
BMC Bioinformatics; 2018 Nov; 19(1):429. PubMed ID: 30453880
[TBL] [Abstract][Full Text] [Related]
15. Validation of the Oncomine
Williams HL; Walsh K; Diamond A; Oniscu A; Deans ZC
Virchows Arch; 2018 Oct; 473(4):489-503. PubMed ID: 30105577
[TBL] [Abstract][Full Text] [Related]
16. Integrative molecular profiling of routine clinical prostate cancer specimens.
Grasso CS; Cani AK; Hovelson DH; Quist MJ; Douville NJ; Yadati V; Amin AM; Nelson PS; Betz BL; Liu CJ; Knudsen KE; Cooney KA; Feng FY; McDaniel AS; Tomlins SA
Ann Oncol; 2015 Jun; 26(6):1110-1118. PubMed ID: 25735316
[TBL] [Abstract][Full Text] [Related]
17. Profiling cancer gene mutations in clinical formalin-fixed, paraffin-embedded colorectal tumor specimens using targeted next-generation sequencing.
Zhang L; Chen L; Sah S; Latham GJ; Patel R; Song Q; Koeppen H; Tam R; Schleifman E; Mashhedi H; Chalasani S; Fu L; Sumiyoshi T; Raja R; Forrest W; Hampton GM; Lackner MR; Hegde P; Jia S
Oncologist; 2014 Apr; 19(4):336-43. PubMed ID: 24664487
[TBL] [Abstract][Full Text] [Related]
18. Integrated approach to generate artificial samples with low tumor fraction for somatic variant calling benchmarking.
Sergi A; Beltrame L; Marchini S; Masseroli M
BMC Bioinformatics; 2024 May; 25(1):180. PubMed ID: 38720249
[TBL] [Abstract][Full Text] [Related]
19. Evaluation and optimisation of indel detection workflows for ion torrent sequencing of the BRCA1 and BRCA2 genes.
Yeo ZX; Wong JC; Rozen SG; Lee AS
BMC Genomics; 2014 Jun; 15(1):516. PubMed ID: 24962530
[TBL] [Abstract][Full Text] [Related]
20. Comparison of whole-exome sequencing of matched fresh and formalin fixed paraffin embedded melanoma tumours: implications for clinical decision making.
De Paoli-Iseppi R; Johansson PA; Menzies AM; Dias KR; Pupo GM; Kakavand H; Wilmott JS; Mann GJ; Hayward NK; Dinger ME; Long GV; Scolyer RA
Pathology; 2016 Apr; 48(3):261-6. PubMed ID: 27020503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
